Detalhe da pesquisa
1.
Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial.
Brain
; 147(3): 849-857, 2024 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37936330
2.
Impact of Baseline Anxiety on Well-being in People with Post-COVID-19 Condition: A Secondary Analysis.
CNS Spectr
; 29(2): 150-154, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38453677
3.
Impact of vortioxetine on psychosocial functioning moderated by symptoms of fatigue in post-COVID-19 condition: a secondary analysis.
Neurol Sci
; 45(4): 1335-1342, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38321333
4.
Impacts of metabolic disruption, body mass index and inflammation on cognitive function in post-COVID-19 condition: a randomized controlled trial on vortioxetine.
Ann Gen Psychiatry
; 23(1): 10, 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38424537
5.
Impact of elevated body mass index (BMI) on cognitive functioning and inflammation in persons with post-COVID-19 condition: a secondary analysis.
Acta Neuropsychiatr
; : 1-7, 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38605630
6.
The bidirectional association of nonalcoholic fatty liver disease with depression, bipolar disorder, and schizophrenia.
CNS Spectr
; 28(5): 541-560, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36268655
7.
Greater Role of Cognitive Impairment Over Fatigue in Post-COVID-19 Quality of Life: A Post-Hoc Analysis of a Randomized Controlled Trial.
medRxiv
; 2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38562760
8.
Association between fatigue and depressive symptoms in persons with post-COVID-19 condition: a post hoc analysis.
Curr Med Res Opin
; : 1-7, 2024 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38860901
9.
Impact of Elevated Body Mass Index (BMI) on Hedonic Tone in Persons with Post-COVID-19 Condition: A Secondary Analysis.
Adv Ther
; 41(2): 686-695, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38114867
10.
Assessing the Effects of Metabolic Disruption, Body Mass Index and Inflammation on Depressive Symptoms in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine.
Adv Ther
; 41(5): 1983-1994, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38520501
11.
Association of SARS-CoV-2 infection with neurological impairments in pediatric population: A systematic review.
J Psychiatr Res
; 170: 90-110, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38134724
12.
The Role of Ketamine in the Treatment of Bipolar Depression: A Scoping Review.
Brain Sci
; 13(6)2023 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37371387
13.
Efficacy, safety, and tolerability of ulotaront (SEP-363856, a trace amine-associated receptor 1 agonist) for the treatment of schizophrenia and other mental disorders: a systematic review of preclinical and clinical trials.
Expert Opin Investig Drugs
; 32(5): 401-415, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37096491
14.
Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: A systematic review.
J Psychiatr Res
; 164: 80-89, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37331261
15.
Association of SARS-CoV-2 Infection with Neurological Symptoms and Neuroimaging Manifestations in the Pediatric Population: A Systematic Review.
Res Sq
; 2023 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36945594